BTIG Maintains Buy on CareDx, Raises Price Target to $28

Benzinga Newsdesk www.benzinga.com Positive 75.9%

Neg 0% Neu 0% Pos 75.9%

BTIG analyst Mark Massaro maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $26 to $28.

Comments

No comments yet. Be the first!